• PDA TR 56

PDA TR 56

  • Technical Report No. 56 Revised 2016 (TR 56) Application of Phase-Appropriate Quality System and cGMP to the Development of Ther
  • Report / Survey by Parenteral Drug Association, 11/01/2016
  • Category: PDA

$325.00 $163.00

PDA's newly revised PDA Technical Report No. 56, Revised 2016 Application of Phase-Appropriate Quality System and cGMP to the Development of Therapeutic Protein Drug Substance provides an overview of the ideal state for broad good manufacturing practices (GMPs) throughout the product lifecycle and as they become more stringent from the discovery/R&D stage through Phase 3 clinical trials to commercial launch. This report also describes a basic framework for clinical trial manufacturing for sites where full commercial development and/or manufacturing may not be the organizational goal (e.g., university/grant-funded investigators, start-up biotech firms).
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

PDA TR 74

PDA TR 74

Technical Report No. 74 (TR 74) Reprocessing of Biopharmaceuticals..

$163.00 $325.00

PDA TR 75

PDA TR 75

Technical Report No. 75 (TR 75) Consensus Method for Rating 0.1?m Mycoplasma Reduction Filters..

$163.00 $325.00

PDA TR 76

PDA TR 76

Technical Report No. 76 (TR 76) Identification and Classification of Visible Nonconformities in Elas..

$163.00 $325.00

PDA TR 56

PDA TR 56

Technical Report No. 56 Revised 2016 (TR 56) Application of Phase-Appropriate Quality System and cGM..

$163.00 $325.00